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Synthetic ohgonucleotides containing putative regulatory sequences are currently employed to identify and isolate genes coding for nuclear binding 
factors. Upstream DNA sequences of eukaryotic genes required for transcriptional activity and tissue specificity can be identified by means of bio- 
chemical techniques as well as computer analysis using homology searching. An alternative approach has been recently proposed by our research 
group. Scanning DNA sequences 1.8 megabases in length from a Genetic Sequence Data Bank, we have identified rare oligonucl~tid~ 5 base 
pairs (bp) long, which are localized within or close to regulatory segments in mammalian promoters. In this paper we demonstrate that the rare 
GTATA sequence identifies an upstream region of the HLA-DRc( gene which operates in conjunction with the sequence AGAAGTCAG, 
homologous to a box found in many interferon-inducible genes, in binding nuclear proteins. 
Gligonuc~otide; DNA-binding factor; HLA-DRe 
I. INTRODUCTION 
Conserved upstream DNA sequences (CUS), playing 
biological functions have been identified in eukaryotic 
genes by means of classical computer approaches 
(homology searching of ‘consensus’ sequences) [l-3] as 
well as by biochemical analyses, including DNA- 
binding protein data 141, footprint analysis [5], and 
CAT assay 16). 
the human HLA-DRar gene [lo], that displays a rare 
5-mer (GTATA) 278 nucleotides upstream of the start 
of transcription 
2. MATERIALS AND METHODS 
2.1. DisFribtction of the GTATA sequence in mammalian upstream 
gene regions 
We have recently proposed a computational ap- 
proach alternative to homology searching, in order to 
identify putative ‘signai’ sequences possibly involved in 
regulating the expression of eukaryotic genes [7,8]. We 
have designed and tested computer programs to 
calculate the frequencies of short oligonucleotides in 
genomic regions [7]. Scanning a 1.8 megabases (Mb) 
genomic sample from the BBN GenBank Genetic Se- 
quence Data Bank [9], rare S-mers have been identified 
that are preferentially located in the non-coding por- 
tions of eukaryotic genes, including the 5 ’ upstream 
regions [S] . 
We used the GenBank Genetic Sequence Data Bank, Release 48.0 
(February, 1987) obtained from BBN Laboratories (Cambridge, MA) 
[9]. The distribution of the S-mer GTATA was analysed in 160 mam- 
mahan promoters at least 41x) bp long (total sampte size of 64 kbp) us- 
ing the PROMOTER program I^i,S]. 
2.2. Synthetic oligonucleotides 
The aim of the present investigation was to test 
whether the analysis of the iocation of rare S-mers could 
be useful to identify DNA regions capable to bind 
nucfear proteins. The model system used in our study is 
The wild-type synthetic oligonucleotides [GTATA/IFN-y (44 bp), 
GTATA-1 (23 bp), GTATA-2 (5 bp), IFN-y-l (21 bp) and IFN-y-2 (9 
bp)] and the mutant synthetic oligonucleotides (Ml, M2, M3 and M4, 
corresponding to the GTATAIIFN-y mer) are shown in Fig. 2B. 
5’-3 ’ strands and the relative complementary strands were synthesiz- 
ed on a Biosearch DNA Synthesizer using the phosphoramidite 
method. Equimolar amounts of each strand were 5’ labelled with 
[r-32P]ATP by the enzyme T4 polynucleotide kinase (Genenco), com- 
bined, heated for 5 min at 80°C in 0.5 M NaCl and annealed for at 
least 30 min at room temperature (RT). 
Correspondence address: R. Gambari, istituto di Chimica Biologica, 
Universita di Ferrara, Via L. Borsari n.46, 44100 Ferrara, Italy 
The human ceh Jines (erythromyeloid K562, B-tymphoid WI-L2, 
promyelocytic HL-60, melanoma MNT-I and MNR-I) f12-141 were 
ali grown in o-medium (Gibco) supplemented with 10 % FCS in 5% 
CO2 at 37’C. The EPC (cyprine epithelioma) cell line (obtained from 
lstituto Zooprofilattico di Torino) was cultured in the same condi- 
tions, except temperature (21°C) for optimal growth. 
Abbreviations: mer, ohgonucieotide; Mb. megabase; bp, base pairs; 
CUS, conserved upstream DNA sequences 
2.4. Ekcitophoretic mobility sR$t assay 
The electrophoretic mobility shift assay (gel retardation) was per- 
formed as originahy described [15] with minor modifications. Nuclear 
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z 
spermidine), in the presence of increasing amounts of po- 
z 6 ly(dI:dC). poly(dI:dC) (Pharmacia, Uppsala, Sweden), 1 pg of 
c3 
6 
-270 -40 
nuclear extract proteins and 0.25 ng of end-labelled ouble-stranded 
V 
oligonucleotides (approximately 50 000 Cerenkow counted cpm), in a 
02 V 
SE3 
total volume of 25 ~1. After 30 min at room temperature, samples 
:; 
were electrophoresed atconstant voltage (300 V for 2 h) through a low 
ou 1 
ionic strength (0.35 x TBE buffer) (1 x TBE = 0.089 M Tris-borate, 
3n 0.089 M boric acid, 0.008 M EDTA) on a 10% polyacrylamide gel un- 
0” L 
til tracking dye (Bromophenol blue) reached the end of the 16 cm slab. 
-330 
Gels were dried and exposed at - 80°C with intensifying screens. 
Nucleotides 
0 
Fig. 1. Distribution of the GTATA rare oligosequence with respect o 3. RESULTS 
the start of transcription (solid arrow) of eukaryotic genes. 160 dif- 
ferent promoters from the GenBank release 48.0 (February 1987) 
(BBN Laboratories, Cambridge, USA) were analysed with the pro- 
gram PROMOTER and the location of the GTATA oligonucleotide 
determined [8]. Results represent he percent of GTATA sequences 
found within segments of 50 nucleotides of the analysed genes. 
extracts were prepared according to Dignam et al. [16] at a protein 
concentration (BCA assay, Pierce Rockford, IL, USA) of l-5 mg/mi. 
Binding reactions, unless otherwise specified, were set up in binding 
buffer (20 mM Tris-HCI, pH 7.6, 50 mM KCl, 1 mM MgCl2, 1 mM 
DTT, 0.2 mM EDTA, 0.01% Triton X-100, 5% glycerol, 0.5 mM 
3.1. Distribution of the GTA TA 5-mer in mammalian 
promoters and its location within the upstream 
sequence of the human HLA-DRa gene 
Fig. 1 shows the distribution of the GTATA mer in 
the upstream region of 160 mammalian promoters. The 
distribution is not random, peaking at about - 270 bp 
and at -40 bp from the start of transcription. While 
the - 40 bp peak identifies the TATA box [17], the 
- 270 bp peak identifies a distinct region. Interestingly, 
the GTATA oligonucleotide of the HLA-DRCY gene is 
HUMAN HLA-DRa GENE 
-593 I FN.a,$ -565 -135 z -117 -7, Y -61 
GTATA AGAAGTCAG CCTAGCAACAGATG 
I FN.Y X 
B Synthetic Ollqonuclcotldes employed 
A. Ylld-type ollqonucleotldcs 
GTATA/I?N-7 “?.er 5’-CTAATGTGCTTCAG~TCCCTGTCT~TTGGGG-3’ 
3p-GATTACACGMGAC.cCGACAGA~AACCCC-5p 
GTATA-1 5’-CTAATGTGCTTCA~TCCC-3’ 
5’-GATTACACGAAGAC~AGGC-5’ 
GTATA-2 5’-GTATA-3’ 
3’-CATAT-5’ 
IFN-I-1 5’ -TGTCT~TTGGGG-3 * 
3’ -ACAGAmMCCCC-5’ 
IFN-l-2 5’.AGAAGTCAG-3’ 
3’.TCTTCA@TC-5’ 
n-1 5’-CTAATGTGCTTCAG~TCCCTGTCT~ATTGGGG-38 
3’-GATTACACGMGTC~AGGGACAGMGAGAAGTCTAACCCC-51 
n-2 5’-CTAATGTGCTTCAG~TCCCTGTCT~ATTGGGG-3° 
3’.CATTACACGMGT~~GGGACAGA~TAACCCC-5’ 
“-3 5’ -CTAATCTGCTTCAG~~~TTGGGG-3 I 
3’-GATTACACGAAGTC~CTCTCTcTC,~~AACCCC-5q 
n-r 5’-CTAATGTGCTTCAG!iii&CCTGTCT~ATTGGGG-3t 
I’-GATTACACGAAGTCT~GGGACAGAAGAGAAGTCTMCCCC-5, 
Fig. 2. (A) Location and sequences of putative regulatory boxes (& y, z, IFN-7, IFN-a,& of the human HLA-DRor gene [lo]. The location of 
the rare GTATA oligosequence (- 278) is indicated. (B) Sequences of the synthetic wild-type (GTATA/IFN-7, IFN-y-l, IFN-r-2, GTATA-1, 
GTATA-2) and mutant (Ml, M2, M3, M4) oligonucleotides employed. The GTATA and the consensus IFN-7 sequences are underlined. The 
mutated sequences are boxed. 
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positioned at -278 nucleotides from the start of 
transcription, and in close proximity (only 9 
nucleotides) is located the consensus sequence 
AGAAGTCAG (known as IFN-7 box), shared by other 
interferon-inducible genes [l&19] (Fig. 2A). 
3.2. The GTATA S-mer identi~es a sequence required 
for binding nuclear proteins 
When 5’ end 32P-labelled GTATA/IFN-7 mer (the 
sequences of the synthetic oligonucleotides used are 
shown in Fig. 2B) is incubated with nuclear extracts 
from cell lines of different histotype, a reproducible gel 
retardation pattern is obtained. At the highest (400 ng) 
poly(dI:dC) concentration, the binding of non-specific 
protein(s) (Bl) and low-affinity factors (B2,B4) to 32P- 
labelled GTATA/IFN--/ mer is either diminished or 
absent, while binding of the B3 factor appears to be on- 
ly slightly affected (Fig. 3A). This result suggests that 
B3 exhibits the highest affinity for the GTATAIIFN-r 
mer, and was confirmed by five independent ex- 
periments (see also Fig. 4 and Fig. 5). Nuclear extract 
proteins from the epithelioma papulosum carp fish cell 
line in the presence of the GTATA/IFN-y mer, did not 
generate any band shift comparable to the fs3 retarded 
band (Fig. 3B). Competition experiments demonstrate 
that the B3 band disappears only when cold 
GTATA/IFN--, mer is added to the binding reaction 
(data not shown). In contrast, no competition resulted 
with the z-box oligonucleotide except when added at 
high concentrations (200 ng125 Icf of reactions) (data 
not shown). 
Fig. 4 shows that while the GTATA/IFN-7 mer is 
able to bind nuclear factors, both IFN-7-l and 
GTATA-1 mers do not give rise to any specific complex 
9 K562 WI-L2 MNT-1 MRN-1 HL60 II B -- --- 
81 . 81 . El . 
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84 o 483 14 t 
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Fig. 3. Gel retardation assays of the binding of nuclear proteins from 
different cell lines to the GTATA/IFN-7 oligonucleotide. (A) 1 cg of 
nuclear extracts from the erythromyeloid K562, the B-lymphoid WI- 
L2, the promyelocytic HL60 and the melanoma, MNT-1 and MNR-1 
cell lines were allowed to bind to 0.25 ng of 5’ end-labelled 
GTATA/IFN-r mer in a final volume of 25 ~1 in presence of the in- 
dicated amounts of poly(dI:dC)(dI:dC). After 30 min binding at 
room temperature, the reaction mixtures were electrophoresed on 8% 
polyacrylamide gels. (B) Binding of the GTATADFN-y mer to 
nuclear extracts from the EPC carp fish cell line. Bl-B4 indicate 
.5124.5124.5124 
na (~16~) 
Fig. 4. Analysis by gel retardation of the binding of nuclear proteins 
to the GTATA/IFN-7, GTATA-1 and IFN-y mers. The assay was 
performed using 1 fig of proteins of a nuclear extract prepared from 
a B-tymphoid WI-L2 cell line. Bl-B4 indicate retarded bands. The in- 
dicated concentrations of competitor poly(dI:dC)(dI:dC) were includ- 
ed in the binding reactions (25 ~1). The sequences of the 
retarded bands; f = free GTATA/IFN-r 5’ end labelled mer. oligonucleotides employed are shown in Fig. 2B. 
with the B3 factor, suggesting that simultaneous 
presence of the GTATA and AGAAGTCAG boxes is 
mandatory for optimal binding of the nuclear factors. 
3.3. Effects of mutations in the GTATA and AGA- 
AGTCAG sequences on binding of the B3 
factor(s~ 
In order to investigate the role of GTATA and 
AGAAGTCAG sequences on the binding of the B3 
nuclear factor two sets of experiments were performed 
using the mutant oligonucleotides hown in Fig. 2B. In 
the first set of experiments (Fig. 5A) the binding of the 
B3 factor to the mutant oligonu~leotides was determin- 
ed. In the second set of experiments cold mutant 
oligonucleotides were used to compete for the binding 
of the B3 factor to the 32P-labelled GTATA/IFN-r mer 
(Fig. 5B). 
The results shown in Fig. 5A demonstrate that, since 
the M3 oligonucleotide binds the B3 factor, mutating 
the TCCCTGTCT sequence of the oligonucleotide 
GTATA/IFN-y does not affect the binding. This sug- 
gests that the sequence of the 9 bp spacer between 
GTATA and AGAAGTCAG in the upstream region of 
the human HLA-DRa gene does not affect recognition 
of the B3 factor. Conversely, mutations in the GTATA, 
AGAAGTCAG or both do affect binding of the B3 
nuclear factor, suggesting that the simultaneous 
presence of GTATA and AGAAGTCAG sequences is 
required for binding of the B3 factor(s). 
Ad~tionally, Fig. 5B shows that Ml, M2 and M4 
mers have low capacity for competing with the 
GTATA/IFN-r oligomer, while the extent of competi- 
tion by the M3 oligonucleotide was similar to that of the 
GTATA/IFN-r mer. 
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Fig. 5. Effects of mutations on the bindi~ of the GTATAIIFN-y 
mer to the I33 factor(s). In this experiment nuclear extracts from the 
MRN-1 cell line were used. (A) Binding of GTATA/IFN-7, Ml, M2, 
M3 and M4 oligonucleotides to nuclear factors. Bl-B4: retarded 
bands; f = free oligonucleotide. The amounts of poly(dI:dC)(dI:dC) 
competitor are indicated. (B) Competition by GTATA/IFN-7 (e), 
Ml (O), M2 (A), M3 (m) and M4 (A) mers in the binding of nuclear 
factors to the 5’-end labelled GTATA/IFNr oligonucleotide. Up = 
autora~ograms; down left = densitometric analysis; down right = 
comparison of the effects of 50 ng of GTATA/IFN-y and mutant 
oligonucleotides in the binding of 32P-labelled GTATA/IFN-y mer to 
the B3 factor(s). Binding reactions (25 ~1) were carried on for 30 min 
at room temperature in the presence of the indicated ng of cold com- 
petitors. The sequences of the oligo~ucleotides employed are shown 
in Fig. 2B. 
4. DISCUSSION 
In this paper we describe the identification of a se- 
quence located within the upstream region of the 
human HLA-DR~u gene, that (i) contains a rare 5-mer, 
GTATA, and (ii) specifically binds nuctear proteins. 
Rare 5-mers were identified by means of a computer- 
assisted analysis using a non-homology search ap- 
proach [7,8] and were found in some instances to Occur 
in close proximity t5 regulatory elements of mammalian 
promoters [8]. The DNA region centered around the se- 
quence GTATA is located just 5’ of the so-called IFN--, 
consensus equences [19-211 as shown in Fig. 2A. 
By means of gel-retardation assay, we demonstrate 
that the synthetic double-stranded oligonudeotide con- 
taining both GTATA and IFN-r boxes is able to form 
specific complexes with nuclear factors (retarded band 
B3 of Fig. 3, Fig. 4 and Fig. 5) from cell lines of dif- 
ferent histotype. 
54 
Our data show that, if the GTATA, the 
AGAAGTCAG sequences or both are mutated (Fig. 5) 
or deleted (Fig. 4), the binding to the B3 factor is much 
reduced. Taken together, these results consistently in- 
dicate that the presence of both GTATA and IFN-y box 
is required for the binding of the B3 factor(s). Although 
the roie of the GTATA/IFN-~ sequence and the bin- 
ding factors remains to be elucidated, our data suggest 
that the combination of different computer-aided 
analyses is a useful too1 in identifying upstream se- 
quences which bind nuclear proteins. 
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